Welcome to our dedicated page for TILRAY BRANDS news (Ticker: TLRY), a resource for investors and traders seeking the latest updates and insights on TILRAY BRANDS stock.
Tilray Brands Inc. (TLRY) maintains a dynamic presence in global cannabis markets through its medical research initiatives and consumer product innovations. This resource provides investors and industry observers with centralized access to verified corporate announcements, regulatory developments, and market analysis.
Users will find updates spanning earnings reports, international expansion efforts, and product portfolio enhancements, including developments in cannabis-infused wellness solutions. The curated selection enables stakeholders to track operational milestones across Tilray's pharmaceutical-grade production facilities and lifestyle brand divisions.
All content undergoes strict verification to ensure alignment with financial disclosure standards and industry regulations. Regular updates reflect Tilray's position as a GMP-certified producer serving medical markets in 20+ countries while expanding recreational offerings in emerging markets.
Bookmark this page for streamlined monitoring of Tilray's strategic initiatives, quality control advancements, and responses to evolving cannabis legislation worldwide.
Tilray Brands (NASDAQ:TLRY; TSX:TLRY), a leading global lifestyle and consumer packaged goods company focused on beverage, cannabis, and wellness industries, has scheduled its fourth quarter and fiscal year 2025 earnings release for July 28, 2025, after market close.
The company will host a conference call and audio webcast to discuss the results at 4:30 PM Eastern Time. Investors can access the webcast through the Events & Presentations section of Tilray's Investor Relations website.
Tilray Brands (Nasdaq: TLRY; TSX: TLRY) has announced Independence Day celebrations across its craft beer taproom locations throughout the United States. The company's portfolio of breweries including 10 Barrel Brewing, Atwater Brewery, Blue Point Brewing, Breckenridge Brewery, Montauk Brewing Company, SweetWater Brewing Co, and Terrapin Beer Co will host various events and special offers.
Each location will feature unique celebrations including live music, BBQ specials, limited-release beers, and holiday festivities. Notable events include Breckenridge Farmhouse's Arapahoe Philharmonic orchestra performance with tickets ranging from $14-$475, Montauk Brewing's limited-edition Après Surf Beer release, and Blue Point Brewing's Boardy Barn event featuring special beer pricing and entertainment.
The celebrations will include family-friendly activities at most locations, with special food and beverage promotions such as Atwater Brewery's $15 BBQ meal deals and $20 beer buckets, and various to-go beer specials across different locations.
Breckenridge Distillery, a craft spirits brand owned by Tilray Brands, Inc. (NASDAQ: TLRY), has announced its fifth edition of the Collectors Art Series featuring a collaboration with artist Miles Toland for their new Calvados Cask Finish whiskey.
The limited-edition release, bottled at 95 proof (47.5% ABV) and priced at $125, features Toland's artwork depicting a figure surrounded by Colorado's Rocky Mountains and lark buntings dissolving into a mandala. The whiskey offers notes of red apples, warm oak, vanilla, and cinnamon spice.
As part of the initiative, $5 from each bottle sold will be donated to Keep RiNo Wild (KRW), a 501(c)(3) organization supporting permanent, affordable community creative spaces. The release will be available exclusively at Breckenridge Distillery and the Main Street Tasting Room in Breckenridge, Colorado, starting July 1, 2025.
Montauk Brewing Co., a craft beer brand under Tilray Brands (NASDAQ: TLRY), announces a collaboration with premium lifestyle brand Faherty to celebrate its 13th anniversary. The partnership features the launch of The Après Surf Beer, a tropical variant of their Golden Ale, and a limited-edition apparel collection.
The collaboration includes a beach cleanup event with the Eastern Long Island Chapter of Surfrider Foundation on June 28th, 2025. The limited-edition beer will be exclusively available at the Montauk Brew Barn, while the apparel collection will be sold online through Montauk Brewing's website.
Tilray Medical (NASDAQ:TLRY) has published groundbreaking research comparing the bioavailability of different THC:CBD formulations. The study examined two delivery methods: oral administration of Tilray THC:CBD extract versus oromucosal administration of nabiximols.
The pilot crossover study, involving 12 healthy volunteers, revealed that Tilray's oral THC:CBD extract achieved significantly higher maximum concentrations (Cmax) of THC and CBD compared to nabiximols. Notably, nabiximols showed higher effectiveness in males versus females. The research found no serious adverse events, with both compounds becoming undetectable after 24 hours.
This research advances understanding of cannabinoid pharmacokinetics and demonstrates Tilray's commitment to developing effective medical cannabis solutions across more than 20 countries.
Tilray Medical (NASDAQ: TLRY), a division of Tilray Brands, has achieved a historic milestone by becoming the first company to receive authorization from Italy's Ministry of Health to import and distribute medical cannabis flower for therapeutic use. Through its subsidiary FL Group, the company will introduce three new medical cannabis varieties in Italy: Tilray THC 25%, Tilray THC 18%, and Tilray THC 9% / CBD 9%.
The products, which are EU-GMP certified, will be available through pharmacies across Italy starting June 2025. This expansion strengthens Tilray's European presence, where it already operates in Germany, Portugal, Poland, and the United Kingdom.